Multicenter evaluation of the BD Phoenix automated microbiology system for antimicrobial susceptibility testing of Streptococcus species

Journal of Clinical Microbiology

Volumn 45, Issue 9, 2007, Pages 2863-2871

  Richter, Sandra S ^a   Howard, Wanita J ^a   Weinstein, Melvin P ^b   Bruckner, David A ^c   Hindler, Janet F ^c   Saubolle, Michael ^d   Doern, Gary V ^a  

^a UNIVERSITY OF IOWA   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Laboratory Sciences of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DIAGNOSTIC ERRORS; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 34548666593     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00981-07     Document Type: Article

References (14)

1. Beekmann, S. E., K. P. Heilmann, S. S. Richter, J. Garcia-de-Lomas, G. V. Doern, and the GRASP Study Group. 2005. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-hemolytic streptococci in 2002-2003; results of the multinational GRASP surveillance program. Int. J. Antimicrob. Agents 25:148-156.
2. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - seventh edition. CLSI document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute/NCCLS. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Diekema, D. J., M. L. Beach, M. A. Pfaller, R. N. Jones, and the SENTRY Participant Group. 2001. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada, and Latin America. Clin. Microbiol. Infect. 7:152-157.
5. Doern, G. V., M. J. Ferraro, A. B. Brueggemann, and K. L. Ruoff. 1996. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40:891-894.
6. Doern, G. V., S. S. Richter, A. Miller, N. Miller, C. Rice, K. Heilmann, and S. Beekmann. 2005. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin. Infect. Dis. 41:139-148.
7. Food and Drug Administration. 5 March 2007. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for industry and FDA. Food and Drug Administration, Rockville, MD. http://www.fda.gov/cdrh/oivd/guidance/631.html.
8. Jorgensen, J. H., A. L. Barry, M. M. Traczewski, D. F. Sahm, M. L. McElmeel, and S. A. Crawford. 2000. Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2. J. Clin. Microbiol. 38:2814-2818.
9. Jorgensen, J. H., S. A. Crawford, L. M. McElmeel, and C. G. Whitney. 2004. Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument. J. Clin. Microbiol. 42:5928-5930.
10. Lin, F.-Y. C., P. H. Azimi, L. E. Weisman, J. B. Philips, J. Regan, P. Clark, G. G. Rhoads, J. Clemens, J. Troendle, E. Pratt, R. A. Brenner, and V. Gill. 2000. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin. Infect. Dis. 31:76-79.
11. Murdoch, D. R., and L. B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated form patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother. 45:3623-3624.
12. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, A. L. Miller, C. L. Rice, C. D. Doern, S. D. Reid, and G. V. Doern. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
13. Schrag, S., R. Gorwitz, K. Fultz-Butts, and A. Schuchat. 2002. Prevention of perinatal group B streptococcal disease, revised guidelines from CDC. Morb. Mortal. Wkly. Rep. 51(RR-11):1-22.
14. Tang, P., P. Ng, M. Lum, M. Skulnick, G. W. Small, D. E. Low, A. Sarabia, T. Mazzulli, K. Wong, A. E. Simor, and B. M. Willey. 2004. Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci. J. Clin. Microbiol. 42:2282-2284.